This study is testing whether sending official digital letters can help more people with heart failure start taking a recommended medication called an SGLT-2 inhibitor. The goal is to get eligible patients on this treatment faster than the current process allows. Researchers are …
Phase: NA • Sponsor: Morten Schou • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC